Your Partner in Innovation

At Cellipont Bioservices, we offer comprehensive service solutions for cutting-edge cell and gene therapies. Our expertise spans Allogeneic and CAR-T cell therapies, iPSC development, and upcoming Exosome services, all supported by our purpose-built manufacturing facility. With a focus on scalability, safety, and efficacy, we empower our partners to bring transformative treatments from concept to clinic.

Other services include: DCs, Fibroblasts, NK, HSCs, TIL, Cell Banking (MCB, WCB), and Feeder Cell Banks. Contact [email protected] to inquire further about other services.

Innovative Services:

• Allogeneic Cell Therapy: Advanced manufacturing capabilities and comprehensive support services for efficient production, viability, and distribution.
• CAR-T Services: From process development to commercial manufacturing, our extensive services are tailored to meet your unique project requirements.
• iPSCs: Specialized expertise in reprogramming, differentiation, and safety assurance for diverse iPSC-derived cell therapies.
• Exosomes: State-of-the-art manufacturing capabilities (coming soon in 2025) for scalable production, purification, and characterization of customized therapeutic exosomes in a versatile Ballroom-style Flex Suite.

Contact us at [email protected] for more info on our client services.